Fragile sites and human disease

Human Molecular Genetics

Volumn 16, Issue R2, 2007, Pages

  Debacker, Kim ^a   Frank Kooy, R ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME DISORDER; CHROMOSOME FRAGILE SITE; DNA REPLICATION; FEMALE; FRAGILE X SYNDROME; GENETICS; GENOME; HUMAN; MALE; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; REVIEW; TRINUCLEOTIDE REPEAT;

BASE SEQUENCE; CHROMOSOME DISORDERS; CHROMOSOME FRAGILE SITES; DNA REPLICATION; EVOLUTION, MOLECULAR; FEMALE; FRAGILE X SYNDROME; GENOME, HUMAN; HUMANS; MALE; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 38449093969     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm136     Document Type: Article

References (102)

1. Sutherland, G.R. (1991) Chromosomal fragile sites. Genet. Anal. Tech. Appl., 8, 161-166.
2. Schwartz, M., Zlotorynski, E. and Kerem, B. (2005) The molecular basis of common and rare fragile sites. Cancer Lett., 232, 13-26.
3. Kooy, R.F., Oostra, B.A. and Willems, P.J. (1998) The fragile X syndrome and other fragile site disorders. Results Probl. Cell Differ., 21, 1-46.
4. Sutherland, G.R. (2003) Rare fragile sites. Cytogenet. Genome Res., 100, 77-84.
5. Ruiz-Herrera, A., Garcia, F., Fronicke, L., Ponsa, M., Egozcue, J., Garcia Caldes, M. and Stanyon, R. (2004) Conservation of aphidicolin-induced fragile sites in Papionini (Primates) species and humans. Chromosome Res., 12, 683-690.
6. Shiraishi, T., Druck, T., Mimori, K., Flomenberg, J., Berk, L., Alder, H., Miller, W., Huebner, K. and Croce, C.M. (2001) Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit. Proc. Natl. Acad. Sci. USA, 98, 5722-5727.
7. Krummel, K.A., Denison, S.R., Calhoun, E., Phillips, L.A. and Smith, D.I. (2002) The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer, 34, 154-167.
8. Arlt, M.F., Durkin, S.G., Ragland, R.L. and Glover, T.W. (2006) Common fragile sites as targets for chromosome rearrangements. DNA Repair, 5, 1126-1135.
9. Verkerk, A.J.M.H., Pieretti, M., Sutcliffe, J.S., Fu, Y.-H., Kuhl, D.P.A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
10. Knight, S.J.L., Voelckel, M.A., Hirst, M.C., Flannery, A.V., Moncla, A. and Davies, K.E. (1994) Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. Am. J. Hum. Genet., 55, 81-86.
11. Sutherland, G.R. and Hecht, F. (1985) Fragile Sites on Human Chromosomes. Oxford University Press, New York.
12. Knight, S.J.L., Flannery, A.V., Hirst, M.C., Campbell, L., Christodoulou, Z., Phelps, S.R., Pointon, J., Middleton-Price, H.R., Barnicoat, A., Pembrey, M.E. et al. (1993) Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell, 74, 127-134.
13. Parrish, J.E., Oostra, B.A., Verkerk, A.J.M.H., Richards, C.S., Reynolds, J., Spikes, A.S., Shaffer, L.G. and Nelson, D.L. (1994) Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat. Genet., 8, 229-235.
14. Nancarrow, J.K., Kremer, E., Holman, K., Eyre, H., Doggett, N.A., Le Paslier, D., Callen, D.F., Sutherland, G.R. and Richards, R.I. (1994) Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science, 264, 1938-1941.
15. Jones, C., Penny, L., Mattina, T., Yu, S., Baker, E., Voullaire, L., Langdon, W.Y., Sutherland, G.R., Richards, R.I. and Tunnacliffe, A. (1995) Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature, 376, 145-149.
16. Sarafidou, T., Kahl, C., Martinez-Garay, I., Mangelsdorf, M., Gesk, S., Baker, E., Kokkinaki, M., Talley, P., Maltby, E.L., French, L. et al. (2004) Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein. Genomics, 84, 69-81.
17. Winnepenninckx, B., Debacker, K., Ramsay, J., Smeets, D., Smits, A., FitzPatrick, D.R. and Kooy, R.F. (2007) CGG repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1. Am. J. Hum. Genet., 80, 221-231.
18. Debacker, K., Winnepenninckx, B., Longman, C., Colgan, J., Tolmie, J., Murray, R., van Luijk, R., Scheers, S., FitzPatrick, D. and Kooy, R.F. (2007) The molecular basis of the folate-sensitive fragile site FRA11A at 11q13. Cytogenet. Genome Res., in press.
19. Yu, S., Mangelsdorf, M., Hewett, D., Hobson, L., Baker, E., Eyre, H.J., Lapsys, N., Le Paslier, D., Doggett, N.A., Sutherland, G.R. et al. (1997) Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell, 88, 367-374.
20. Hewett, D.R., Handt, O., Hobson, L., Mangelsdorf, M., Eyre, H.J., Baker, E., Sutherland, G.R., Schuffenhauer, S., Mao, J.I. and Richards, R.I. (1998) FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol. Cell, 1, 773-781.
21. Handt, O., Sutherland, G.R. and Richards, R. (2000) Fragile sites and minisatellite repeat instability. Mol. Genet. Metab., 70, 99-105.
22. Arlt, M.F., Casper, A.M. and Glover, T.W. (2003) Common fragile sites. Cytogenet. Genome Res., 100, 92-100.
23. Hormozian, F., Schmitt, J.G., Sagulenko, E., Schwab, M. and Savelyeva, L. (2006) FRA1E common fragile site breaks map within a 370 kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD). Cancer Lett., 246, 82-91.
24. Limongi, M.Z., Pelliccia, F. and Rocchi, A. (2003) Characterization of the human common fragile site FRA2G. Genomics, 81, 93-97.
25. Wilke, C.W., Hall, B.K., Hohe, A., Paradee, W., Smith, D.I. and Glover, T.W. (1996) FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5, 187-195.
26. Ong, S.T., Fong, K.M., Bader, S.A., Minna, J.D., Le Beau, M.M., McKeithan, T.W. and Rassool, F.V. (1997) Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines. Genes Chromosomes Cancer, 20, 16-23.
27. Rozier, L., El-Achkar, E., Apiou, F. and Debatisse, M. (2004) Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer. Oncogene, 23, 6872-6880.
28. Denison, S.R., Callahan, G., Becker, N.A., Phillips, L.A. and Smith, D.I. (2003) Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer, 38, 40-52.
29. Morelli, C., Karayianni, E., Magnanini, C., Mungall, A.J., Thorland, E., Negrini, M., Smith, D.I. and Barbanti-Brodano, G. (2002) Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene, 21, 7266-7276.
30. Zlotorynski, E., Rabat, A., Skaug, J., Ben-Porat, N., Ozeri, E., Hershberg, R., Levi, A., Scherer, S.W., Margalit, H. and Kerem, B. (2003) Molecular basis for expression of common and rare fragile sites. Mol. Cell Biol., 23, 7143-7151.
31. Huang, H., Qian, J., Proffit, J., Wilber, K., Jenkins, R. and Smith, D.I. (1998) FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites. Oncogene, 16, 2311-2319.
32. Mishmar, D., Rahat, A., Scherer, S.W., Nyakatura, G., Hinzmann, B., Kohwi, Y., Mandel-Gutfroind, Y., Lee, J.R., Drescher, B., Sas, D.E. et al. (1998) Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc. Natl. Acad. Sci. USA, 95, 8141-8146.
33. Ciullo, M., Debily, M.A., Rozier, L., Autiero, M., Billault, A., Mayau, V., El Marhomy, S., Guardiola, J., Bernheim, A., Coullin, P., Piatier-Tonneau, D. and Debatisse, M. (2002) Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum. Mol. Genet., 11, 2887-2894.
34. Ferber, M.J., Thorland, E.C., Brink, A.A.T.P., Rapp, A.K., Phillips, L.A., McGovern, R., Gostout, B.S., Cheung, T.H., Chung, T.K.H., Fu, W.Y. et al. (2003) Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene, 22, 7233-7242.
35. Callahan, G., Denison, S.R., Phillips, L.A., Shridhar, V. and Smith, D.I. (2003) Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene, 22, 590-601.
36. Savelyeva, L., Sagulenko, E., Schmitt, J.G. and Schwab, M. (2006) The neurobeachin gene spans the common fragile site FRA13A. Hum. Genet., 118, 551-558.
37. Krummel, K.A., Roberts, L.R., Kawakami, M., Glover, T.W. and Smith, D.I. (2000) The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics, 69, 37-46.
38. Arlt, M.F., Miller, D.E., Beer, D.G. and Glover, T.W. (2002) Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer, 33, 82-92.
39. Curatolo, A., Limongi, Z.M., Pelliccia, F. and Rocchi, A. (2007) Molecular characterization of the human common fragile site FRA1H. Genes Chromosomes Cancer, 46, 487-493.
40. Zlotorynski, E., Rahat, A., Skaug, J., Ben-Porat, N., Ozeri, E., Hershberg, R., Levi, A., Scherer, S.W., Margalit, H. and Kerem, B. (2003) Molecular basis for expression of common and rare fragile sites. Mol. Cell Biol., 23, 7143-7151.
41. Ried, K., Finnis, M., Hobson, L., Mangelsdorf, M., Dayan, S., Nancarrow, J.K., Woollatt, E., Kremmidiotis, G., Gardner, A., Venter, D. et al. (2000) Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet., 9, 1651-1663.
42. Debacker, K., Winnepenninckx, B., Ben-Porat, N., FitzPatrick, R.D., Van Luijk, R., Scheers, S., Kerem, B. and Kooy, R.F. (2007) FRA18C, a new aphidicolin inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage. J. Med. Genet., 44, 347-352.
43. Glover, T.W., Berger, C., Coyle, J. and Echo, B. (1984) DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet., 67, 136-142.
44. Denison, S.R., Simper, R.K. and Greenbaum, I.F. (2003) How common are common fragile sites in humans: interindividual variation in the distribution of aphidicolin-induced fragile sites. Cytogenet. Genome Res., 101, 8-16.
45. Savelyeva, L., Sagulenko, E., Schmitt, J.G. and Schwab, M. (2006) Low-frequency common fragile sites: link to neuropsychiatric disorders? Cancer Lett., 232, 58-69.
46. Sherman, S.L., Jacobs, P.A., Morton, N.E., Froster-Iskenius, U., Howard-Peebles, P.N., Nielsen, K.B., Partington, N.W., Sutherland, G.R., Turner, G. and Watson, M. (1985) Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum. Genet., 69, 3289-3299.
47. Sherman, S.L., Morton, N.E., Jacobs, P.A. and Turner, G. (1984) The marker (X) chromosome: a cytogenetic and genetic analysis. Ann. Hum. Genet., 48, 21-37.
48. Sutherland, G.R. (1982) Heritable fragile sites on human chromosomes. VIII. Preliminary population cytogenetic data on the folic-acid-sensitive fragile sites. Am. J. Hum. Genet., 34, 452-458.
49. Sutherland, G.R. (1985) Heritable fragile sites on human chromosomes. XII. Population cytogenetics. Ann. Hum. Genet., 49, 153-161.
50. Usdin, K. and Grabczyk, E. (2000) DNA repeat expansions and human disease. Cell Mol. Life Sci., 57, 914-931.
51. Pearson, C.E., Edamura, K.N. and Cleary, J.D. (2005) Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet., 6, 729-742.
52. Hansen, R.S., Canfield, T.K., Lamb, M.M., Gartler, S.M. and Laird, C.D. (1993) Association of fragile X syndrome with delayed replication of the FMR1 gene. Cell, 73, 1403-1409.
53. Handt, O., Baker, E., Dayan, S., Gartler, S.M., Woollatt, E., Richards, R.I. and Hansen, R.S. (2000) Analysis of replication timing at the FRA10B and FRA16B fragile site loci. Chromosome Res., 8, 677-688.
54. Le Beau, M.M., Rassool, F.V., Neilly, M.E., Espinosa, R., III, Glover, T.W., Smith, D.I. and McKeithan, T.W. (1998) Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum. Mol. Genet., 7, 755-761.
55. Hellman, A., Rahat, A., Scherer, S.W., Darvasi, A., Tsui, L.C. and Kerem, B. (2000) Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol. Cell Biol., 20, 4420-4427.
56. Palakodeti, A., Han, Y., Jiang, Y. and Le Beau, M.M. (2004) The role of late/slow replication of the FRA16D in common fragile site induction. Genes Chromosomes Cancer, 39, 71-76.
57. Mirkin, S.M. (2006) DNA structures, repeat expansions and human hereditary disorders. Curr. Opin. Struct. Biol., 16, 351-358.
58. Wang, Y.-H., Gellibolian, R., Shimizu, M., Wells, R.D. and Griffith, J. (1996) Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. J. Mol. Biol., 263, 511-516.
59. Hsu, Y.Y. and Wang, Y.H. (2002) Human fragile site FRA16B DNA excludes nucleosomes in the presence of distamycin. J. Biol. Chem., 277, 17315-17319.
60. Miró, R., Clemente, I.C., Fuster, C. and Egozcue, J. (1987) Fragile sites, chromosome evolution, and human neoplasia. Hum. Genet., 75, 345-349.
61. Ruiz-Herrera, A., Garcia, F., Giulotto, E., Attolini, C., Egozcue, J., Ponsa, M. and Garcia, M. (2005) Evolutionary breakpoints are co-localized with fragile sites and intrachromosomal telomeric sequences in primates. Cytogenet. Genome Res., 108, 234-247.
62. Ruiz-Herrera, A., Castresana, J. and Robinson, T.J. (2006) Is mammalian chromosomal evolution driven by regions of genome fragility? Genome Biol., 7, R115.
63. Lubs, H.A. (1969) A marker X chromosome. Am. J. Hum. Genet., 21, 231-244.
64. Gantois, I., Kooy, R.F. and Oostra, B.A. (2004) Insights in fragile X syndrome. In Meyers, R.A. (ed.), Encyclopedia of Molecular Cell Biology and Molecular Medicine, Wiley-VCH, Weinheim, Germany, pp. 585-631.
65. Hagerman, R.J. (2002) Physical and behavioral phenotype. In Hagerman, R.J. and Hagerman, P.J. (eds), Fragile X Syndrome: Diagnosis, Treatment and Research, 3rd edn. Johns Hopkins University Press, Baltimore, MA, pp. 3-109.
66. Bardoni, B., Davidovic, L., Bensaid, M. and Khandjian, E.W. (2006) The fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev. Mol. Med., 8, 1-16.
67. O'Donnell, W.T. and Warren, S.T. (2002) A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci., 25, 315-338.
68. Weisman-Shomer, P., Cohen, E. and Fry, M. (2000) Interruption of the fragile X syndrome expanded sequence d(CGG)(n) by interspersed d(AGG) trinucleotides diminishes the formation and stability of d(CGG)(n) tetrahelical structures. Nucleic Acids Res., 28, 1535-1541.
69. Garber, K., Smith, K.T., Reines, D. and Warren, S.T. (2006) Transcription, translation and fragile X syndrome. Curr. Opin. Genet. Dev., 16, 270-275.
70. Hagerman, P.J. and Hagerman, R.J. (2004) Fragile X-associated tremor/ ataxia syndrome (FXTAS). Ment.Retard.Dev. Disabil. Res. Rev., 10, 25-30.
71. Zhong, N., Ju, W., Curley, D., Wang, D., Pietrofesa, J., Wu, G., Shen, Y., Pang, C., Poon, P., Liu, X. et al. (1996) A survey of FRAXE allele sizes in three populations. Am. J. Med. Genet., 64, 415-419.
72. Gécz, J., Oostra, B.A., Hockey, A., Carbonell, P., Turner, G., Haan, E.A., Sutherland, G.R. and Mulley, J.C. (1997) FMR2 expression in families with FRAXE mental retardation. Hum. Mol. Genet., 6, 435-441.
73. Gu, Y. and Nelson, D.L. (2003) FMR2 function: insight from a mouse knockout model. Cytogenet. Genome Res., 100, 129-139.
74. Gecz, J. (2000) The FMR2 gene, FRAXE and non-specific X-linked mental retardation: clinical and molecular aspects. Ann. Hum. Genet., 64, 95-106.
75. Taki, T., Kano, H., Taniwaki, M., Sako, M., Yanagisawa, M. and Hayashi, Y. (1999) AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11) (q31;q13q23. Proc. Natl. Acad. Sci. USA, 96, 14535-14540.
76. Hiwatari, M., Taki, T., Taketani, T., Taniwaki, M., Sugita, K., Okuya, M., Eguchi, M., Ida, K. and Hayashi, Y. (2003) Fusion of an AF4-related gene, LAF4, to MLL in childhood acute lymphoblastic leukemia with t(2;11)(q11;q23). Oncogene, 22, 2851-2855.
77. Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C.M. and Canaani, E. (1992) The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell, 71, 701-708.
78. Hillman, M.A. and Gecz, J. (2001) Fragile XE-associated familial mental retardation protein 2 (FMR2) acts as a potent transcription activator. J. Hum. Genet., 46, 251-259.
79. Gecz, J. (2000) FMR3 is a novel gene associated with FRAXE CpG island and transcriptionally silent in FRAXE full mutations. J. Med. Genet., 37, 782-784.
80. Glover, T.W. (2006) Common fragile sites. Cancer Lett., 232, 4-12.
81. Coquelle, A., Pipiras, E., Toledo, F., Buttin, G. and Debatisse, M. (1997) Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell, 89, 215-225.
82. Rassool, F.V., McKeithan, T.W., Neilly, M.E., van Melle, E., Espinosa, I.I.I.R. and Le Beau, M.M. (1991) Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites. Proc. Natl. Acad. Sci. USA, 88, 6657-6661.
83. Glover, T.W., Arlt, M.F., Casper, A.M. and Durkin, S.G. (2005) Mechanisms of common fragile site instability. Hum. Mol. Genet., 14, R197-R205.
84. Iliopoulos, D., Guler, G., Han, S.-Y., Druck, T., Ottey, M., McCorkell, K.A. and Huebner, K. (2006) Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett., 232, 27-36.
85. Pekarsky, Y., Palamarchuk, A., Huebner, K. and Croce, C.M. (2002) FHIT as tumor suppressor: mechanisms and therapeutic opportunities. Cancer Biol. Ther., 1, 232-236.
86. O'Keefe, L.V. and Richards, R.I. (2006) Common chromosomal fragile sites and cancer: focus on FRA16D. Cancer Lett., 232, 37-47.
87. Brewer, C.M., Lam, W.W., Hayward, C., Grace, E., Maher, E.R. and FitzPatrick, D.R. (1998) Beckwith-Wiedemann syndrome in a child with chromosome 18q deletion. J. Med. Genet., 35, 162-164.
88. Dekaban, A. (1965) Persisting clone of cells with an abnormal chromosome in a woman previously irradiated. J. Nucl. Med., 6, 740-746.
89. Sutherland, G.R. (1977) Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science, 197, 265-266.
90. Chudley, A.E., Ray, M., Evans, J.A. and Cheang, M. (1990) Possible association of rare autosomal folate sensitive fragile sites and idiopathic mental retardation: a blind controlled population study. Clin. Genet., 38, 241-256.
91. Kähkönen, M., Tengstrom, C., Alitalo, T., Matilainen, R., Kaski, M. and Airaksinen, E. (1989) Population cytogenetics of folate-sensitive fragile sites. II. Autosomal rare fragile sites. Hum. Genet., 82, 3-8.
92. Mavrou, A., Syrrou, M., Tsenghi, C. and Metaxotou, C. (1991) Autosomal folate sensitive fragile sites in normal and mentally retarded individuals in Greece. Am. J. Med. Genet., 38, 437-439.
93. Fryns, J.P. and Petit, P. (1987) Population cytogenetics of autosomal fragile sites. Clin. Genet., 31, 61-62.
94. Kähkönen, M., Leisti, J., Thoden, C.J. and Autio, S. (1986) Frequency of rare fragile sites among mentally subnormal schoolchildren. Clin. Genet., 30, 234-238.
95. Petit, P., Fryns, J.P., van den Berghe, H. and Hecht, F. (1986) Population cytogenetics of autosomal fragile sites. Clin. Genet., 29, 96-100.
96. Webb, T.P., Thake, A.I., Bundey, S.E. and Todd, J. (1987) A cytogenetic survey of a mentally retarded school-age population with special reference to fragile sites. J. Ment. Defic. Res., 31, 61-71.
97. Sutherland, G.R. and Baker, E. (2000) The clinical significance of fragile sites on human chromosomes. Clin. Genet., 58, 157-161.
98. Berg, J.M., Faunch, J.A., Pendrey, M.J., Penrose, L.S., Ridler, M.A. and Shapiro, A. (1969) A homozygous chromosomal variant. Lancet, 1, 531.
99. Hocking, T., Feichtinger, W., Schmid, M., Haan, E.A., Baker, E. and Sutherland, G.R. (1999) Homozygotes for FRA16B are normal. Chromosome Res., 7, 553-556.
100. Sutherland, G.R. (1981) Heritable fragile sites on human chromosomes. VII. Children homozygous for the BrdU-requiring fra(10)(q25) are phenotypically normal. Am. J. Hum. Genet., 33, 946-949.
101. Hagerman, R.J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B. and Hagerman, P.J. (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 57, 127-130.
102. Tassone, F., Beilina, A., Carosi, C., Albertosi, S., Bagni, C., Li, L., Glover, K., Bentley, D. and Hagerman, P.J. (2007) Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA, 13, 555-562.